Literature DB >> 7513312

Effect of growth factors on Escherichia coli alpha-hemolysin-induced mediator release from human inflammatory cells: involvement of the signal transduction pathway.

B König1, W König.   

Abstract

Previously, we have shown that Escherichia coli alpha-hemolysin represents a potent stimulus for inflammatory mediator release (O2- release, beta-glucuronidase release, and leukotriene generation) from human polymorphonuclear granulocytes (PMN) as well as for histamine release from a human lymphocyte-monocyte-basophil cell suspension (LMB). In contrast, the E. coli alpha-hemolysin leads to a downregulation of cytokine release (interleukin 6 [IL-6], tumor necrosis factor alpha, and IL-1 beta) from human LMB. This study was undertaken (i) to analyze the priming efficacy of growth factors (granulocyte-macrophage colony-stimulating factor [GM-CSF] and granulocyte CSF [G-CSF]) on inflammatory mediator release from human PMN and LMB challenged with hemolysin-producing E. coli bacteria as well as with cell-free E. coli alpha-hemolysin and (ii) to identify major components involved in GM-CSF and G-CSF priming. GM-CSF pretreatment led to an increased chemiluminescence response from human PMN by up to 100%, leukotriene B4 generation was enhanced up to fivefold, and histamine release from human LMB increased from 45% +/- 15% to 75% +/- 5% (mean +/- standard distribution) of the total histamine content. G-CSF priming induced an increase in the chemiluminescence response by up to 50% +/- 5% from human PMN and an increase in histamine release from human LMB by 20% +/- 5%. The growth factors, GM-CSF and G-CSF, modulated neither beta-glucuronidase release from human PMN nor IL-8 release from human PMN and LMB challenged with the E. coli alpha-hemolysin. GM-CSF and G-CSF pretreatment increased the fluoride (NaF)-induced chemiluminescence response by up to 10-fold; the serine/threonine phosphatase inhibitor okadaic acid inhibited GM-CSF- and G-CSF-induced priming. NaF-induced histamine release was enhanced up to 60 and 30% by GM-CSF and G-CSF priming, respectively. GM-CSF and G-CSF pretreatment did not modulate phorbol 12-myristate 13-acetate-induced chemiluminescence response or histamine release. GM-CSF by itself induced an increase in 5-lipoxygenase-specific mRNA expression within 5 min. Our results indicate that (i) GM-CSF and G-CSF interact with inflammatory cells via distinct cellular signalling, (ii) the signal transduction pathway is dependent on the cellular mediator, and (iii) the use of growth factors may be a potent tool to influence the clinical outcome in infectious diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513312      PMCID: PMC186470          DOI: 10.1128/iai.62.5.2085-2093.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Isolation of lymphocytes, granulocytes and macrophages.

Authors:  A Bøyum
Journal:  Scand J Immunol       Date:  1976-06       Impact factor: 3.487

Review 2.  The granulocyte-macrophage colony stimulating factors.

Authors:  D Metcalf
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.

Authors:  T Yoshimura; K Matsushima; S Tanaka; E A Robinson; E Appella; J J Oppenheim; E J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  Human granulocyte chemotactic peptide (IL-8) as a specific neutrophil degranulator: comparison with other monokines.

Authors:  J Willems; M Joniau; S Cinque; J van Damme
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

6.  Tyrosine phosphorylation in human neutrophil.

Authors:  J Gomez-Cambronero; C K Huang; V A Bonak; E Wang; J E Casnellie; T Shiraishi; R I Sha'afi
Journal:  Biochem Biophys Res Commun       Date:  1989-08-15       Impact factor: 3.575

7.  Induction and suppression of cytokine release (tumour necrosis factor-alpha; interleukin-6, interleukin-1 beta) by Escherichia coli pathogenicity factors (adhesions, alpha-haemolysin).

Authors:  B König; W König
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

8.  Arachidonic acid metabolites from polymorphonuclear leukocytes of healthy donors, severely burned patients and children with cystic fibrosis--routine monitoring by high-performance liquid chromatography.

Authors:  J Knöller; W Schönfeld; M Köller; T Hensler; W König
Journal:  J Chromatogr       Date:  1988-06-03

9.  Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals.

Authors:  C A Dahinden; J Zingg; F E Maly; A L de Weck
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

10.  Role of Escherichia coli alpha-hemolysin and bacterial adherence in infection: requirement for release of inflammatory mediators from granulocytes and mast cells.

Authors:  B König; W König; J Scheffer; J Hacker; W Goebel
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

View more
  2 in total

1.  Randomized phase II study of loratadine for the prevention of bone pain caused by pegfilgrastim.

Authors:  J Moukharskaya; D M Abrams; T Ashikaga; F Khan; J Schwartz; K Wilson; C Verschraegen; T Openshaw; J Valentine; J Eneman; P Unger; S Ades
Journal:  Support Care Cancer       Date:  2016-02-19       Impact factor: 3.603

Review 2.  Acylation of Escherichia coli hemolysin: a unique protein lipidation mechanism underlying toxin function.

Authors:  P Stanley; V Koronakis; C Hughes
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.